Asset
Alogliptin Benzoate
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02856113 | phase3 | completed | 2016-10-14 | 2021-08-06 | Takeda | Phase 3 Alogliptin Pediatric Study |
FDA applications (3)
| Application | Type | Applicant |
|---|---|---|
| NDA 022271 | NDA | TAKEDA PHARMACEUTICALS USA INC |
| NDA 022426 | NDA | TAKEDA PHARMACEUTICALS USA INC |
| NDA 203414 | NDA | TAKEDA PHARMACEUTICALS USA INC |
Marketed products (11)
- KAZANO
- KAZANO
- NESINA
- NESINA
- NESINA
- OSENI
- OSENI
- OSENI
- OSENI
- OSENI
- OSENI